Methylergonovine Maleate (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the Methylergonovine Maleate drug offered from KAISER FOUNDATION HOSPITALS. This Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
NON-PROPRIETARY NAME: | Methylergonovine Maleate |
SUBSTANCE NAME: | METHYLERGONOVINE MALEATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-05-31 |
END MARKETING DATE: | 0000-00-00 |
Methylergonovine Maleate HUMAN PRESCRIPTION DRUG Details:
Item Description | Methylergonovine Maleate from KAISER FOUNDATION HOSPITALS |
LABELER NAME: | KAISER FOUNDATION HOSPITALS |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.2(mg/1) |
START MARKETING DATE: | 2012-05-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0179-0122_06763473-e347-4170-8d55-da76c813795e |
PRODUCT NDC: | 0179-0122 |
APPLICATION NUMBER: | ANDA091577 |
Other METHYLERGONOVINE MALEATE Pharmaceutical Manufacturers / Labelers: